Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides

Abstract
We previously induced pathogenic antibodies against anionic phospholipids (PL) in experimental animals by immunization with lipid-free purified human β2glycoprotein I (β2GPI). We hypothesized that antiphospholipid antibodies (aPL) are induced by in vivo binding of foreign b2GPI to self-PL, thus forming an immunogenic complex against which aPL antibodies are produced. If this hypothesis is true, other PL-binding proteins that are products of ubiquitous viral/bacterial agents may also induce aPL. To test this hypothesis, groups of NIH/Swiss mice were immunized with synthetic peptides of viral and bacterial origin that share structural similarity with the putative PL-binding region of β2GPI. Compared with the control groups, animals immunized with the peptides produced significantly higher levels of aPL and anti-β2GPI antibodies. These findings demonstrate that some PL-binding viral and bacterial proteins function like β2GPI in inducing aPL and anti-β2GPI production, and are consistent with a role for such viral and bacterial proteins in inducing aPL antibody production in humans.

This publication has 28 references indexed in Scilit: